The U.S. Surgeon General's report, E-Cigarette Use Among Youth and Young Adults, focuses on the use of e-cigarettes by the youth population. While the majority of the vaping industry agrees that the youth should not use any nicotine product, the report fails to mention the potential tobacco harm reduction benefits of e-cigarettes in adult smokers.
"Nicopure Labs appreciates the U.S. Surgeon General's focus on understanding the vaping industry and the tobacco harm reduction opportunities presented by vaping products," said Jeff Stamler, Chief Executive Officer at Nicopure Labs. "However, we have grave concerns about the report's failure to communicate the unmistakable contribution to increased smoking cessation and the comparative reduced harm presented by vaping products with respect to conventional cigarettes. We expect much more of appointed health officials and we will continue to support reasonable regulation that reflects the potential for harm reduction that vaping products offer to many adult smokers, who otherwise would not have a viable alternative to escape the deadly grip of conventional cigarettes."
"The public would be better served if U.S. Government officials focused their energy and attention on irresponsible manufacturers, and eliminate those who use inappropriate flavor names and employ marketing strategies that appeal to the youth," said Stamler. "The FDA Deeming Rule that went into effect on August 8, 2016 to regulate vaping products does not address this issue, nor the good manufacturing practices and the safety of certain flavorings that most irresponsible manufacturers are using in their e-liquids."
The UK Royal College of Physicians took a much different approach last April and stated that vaping is about 95% safer than smoking and can be used effectively in smoking cessation. The U.S. Surgeon General's report does not mention this.
"We are extremely disappointed that the US Surgeon General Report makes no mention of the UK
Royal College of Physicians comprehensive report published earlier this year, which arrived at different conclusions about the vaping products' potential to reduce harm in various populations, including youth, while duly acknowledging potential risks," said Patricia Kovacevic, General Counsel and Chief Compliance Officer at Nicopure Labs. "Generally, we believe the government's repeated failure to proactively communicate comparative reduced risk of vaping versus smoking is detrimental to public health and does not meet the HHS public health mandate."
About Nicopure Labs, LLC
Operating since 2009, Tampa-based Nicopure Labs, LLC is an industry leading e-liquid manufacturer with operations in the U.S. and Europe. Nicopure Labs has recently upgraded its 110,000-sq. ft. manufacturing and distribution operations in Gainesville, Florida to include a 10,000-sq. ft. ISO 7 cleanroom. Distributing to over 90 countries worldwide, Nicopure Labs has also expanded its presence with the recent addition of a European headquarters in the Netherlands and offices in England.
For more information about Nicopure Labs, distribution or reseller information, please visit nicopure.com. For additional information regarding their premium American-made e-liquids and innovative line of vaporizer devices, please visit halocigs.com.
888-270-2449 ext. 7777
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nicopure-labs-releases-statement-on-the-us-surgeon-generals-report-on-e-cigarettes-300375748.html
SOURCE Nicopure Labs, LLC